Published in Obes Surg on November 01, 2012
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09
Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Surg Endosc (2013) 0.77
Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus. World J Gastroenterol (2014) 0.75
Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus. Gastroenterol Res Pract (2015) 0.75
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care (1991) 9.95
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes (1995) 8.95
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care (2004) 4.57
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care (2005) 1.81
Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis (2009) 1.68
Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis (2009) 1.63
The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab (2011) 1.53
Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg (2010) 1.49
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia (2011) 1.38
Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg (2007) 1.25
Long-term outcomes after gastric bypass. Obes Surg (2005) 1.18
Factors related to weight loss up to 4 years after bariatric surgery. Obes Surg (2011) 1.11
Does diabetes affect weight loss after gastric bypass? Surg Obes Relat Dis (2007) 1.10
Weight loss and health outcomes in African Americans and whites after gastric bypass surgery. Obesity (Silver Spring) (2007) 1.08
Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc (2012) 1.06
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med (2014) 10.66
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg (2003) 4.30
The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg (2010) 3.37
Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care (2014) 3.13
Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med (2010) 2.90
Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2011) 2.46
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes (2008) 2.42
Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab (2004) 2.36
Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med (2006) 2.31
Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem (2009) 2.11
Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis (2009) 2.05
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 1.86
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care (2013) 1.83
Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg (2007) 1.80
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg (2004) 1.77
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70
Brief, four-session group CBT reduces binge eating behaviors among bariatric surgery candidates. Surg Obes Relat Dis (2009) 1.69
Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis (2011) 1.53
Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab (2010) 1.49
Gastrointestinal complications of laparoscopic Roux-en-Y gastric bypass surgery: clinical and imaging findings. Radiology (2002) 1.46
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care (2010) 1.46
Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidates. Surg Obes Relat Dis (2013) 1.45
Medium-term follow-up confirms the safety and durability of laparoscopic ventral hernia repair with PTFE. Surgery (2003) 1.44
LIMITED CARBOHYDRATE REFEEDING INSTRUCTION FOR LONG-TERM WEIGHT MAINTENANCE FOLLOWING A KETOGENIC, VERY-LOW-CALORIE MEAL PLAN. Endocr Pract (2017) 1.39
Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol (2008) 1.36
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr (2010) 1.32
Bariatric surgery and cardiovascular outcomes: a systematic review. Heart (2012) 1.24
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab (2008) 1.17
Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study. PLoS One (2011) 1.17
The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab (2009) 1.16
Laparoscopic era of operations for morbid obesity. Arch Surg (2003) 1.15
Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol (2011) 1.13
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans. Am J Clin Nutr (2009) 1.10
Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg (2012) 1.09
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 1.08
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring) (2009) 1.08
Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis (2010) 1.05
Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg (2004) 1.03
Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) (2011) 1.02
Clinical utility of waist circumference in predicting all-cause mortality in a preventive cardiology clinic population: a PreCIS Database Study. Obesity (Silver Spring) (2009) 1.01
Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc (2011) 1.00
Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 0.99
Revisional bariatric surgery for unsuccessful weight loss and complications. Obes Surg (2013) 0.99
Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg (2010) 0.99
Catastrophizing, pain, and social adjustment in scleroderma: relationships with educational level. Clin J Pain (2006) 0.97
Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg (2003) 0.96
Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool. Surg Obes Relat Dis (2010) 0.95
Positive response to binge eating intervention enhances postoperative weight loss. Surg Obes Relat Dis (2010) 0.94
Jejunal gastrointestinal stromal tumor: a cause of obscure gastrointestinal bleeding. Arch Pathol Lab Med (2004) 0.92
Effects of metformin on weight loss: potential mechanisms. Curr Opin Endocrinol Diabetes Obes (2014) 0.92
Cognitive function is linked to adherence to bariatric postoperative guidelines. Surg Obes Relat Dis (2013) 0.91
Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2). J Obes (2012) 0.91
Pancreatic β-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab (2013) 0.91
Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis (2012) 0.90
Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. Metab Syndr Relat Disord (2011) 0.89
Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes. Ann Surg (2016) 0.89
Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis (2008) 0.89
Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab (2013) 0.89
Exercise training with weight loss and either a high- or low-glycemic index diet reduces metabolic syndrome severity in older adults. Ann Nutr Metab (2012) 0.88
Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery. Obesity (Silver Spring) (2015) 0.88
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.88
Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity (Silver Spring) (2009) 0.87
Complications of gastric bypass: avoiding the Roux-en-O configuration. Obes Surg (2009) 0.87
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis (2012) 0.87
The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis. Rheumatology (Oxford) (2011) 0.87
Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis (2010) 0.86
Quality of life after antireflux surgery compared with nonoperative management for severe gastroesophageal reflux disease. J Am Coll Surg (2002) 0.85
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.85
Psychological risk may influence drop-out prior to bariatric surgery. Surg Obes Relat Dis (2012) 0.85
Visible vs hidden scars and their relation to body esteem. J Burn Care Rehabil (2004) 0.85
'Adiposopathy' and cardiovascular disease: the benefits of bariatric surgery. Curr Opin Cardiol (2013) 0.83
Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations. J Nutr Metab (2011) 0.83
Weighing the evidence for an association between obesity and suicide risk. Surg Obes Relat Dis (2011) 0.83
Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc (2014) 0.83
Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg (2011) 0.81
Bariatric surgery training: getting your ticket punched. J Gastrointest Surg (2007) 0.81
Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis (2011) 0.81
Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis (2011) 0.81
International Diabetes Federation position statement on bariatric surgery for type 2 diabetes: implications for patients, physicians, and surgeons. Surg Obes Relat Dis (2011) 0.81
Outcomes after minimally invasive reoperation for gastroesophageal reflux disease. Ann Thorac Surg (2002) 0.80
Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve. Acta Diabetol (2014) 0.80
Internal consistency and validity assessment of SCL-90-R for bariatric surgery candidates. Surg Obes Relat Dis (2010) 0.80